Delivering larger genes in gene therapy
A new method called “REVeRT” expands the capabilities of gene delivery platforms by transporting larger genes than previously possible.
eye disease
Drops and drugs for diabetic vision loss
Eye injections are the only way to treat diabetic retinopathy, but many refuse to get them. Now, eye drops and pills are on their way.
Safer eye floater treatments come with a burst of nanobubbles
Between invasive surgery or risky laser therapy, people suffering from severe eye floaters have no great treatment options. Now, with the development of a safer and less invasive nanoparticle-based therapy, people with floaters may finally get their vision and quality of life back.
miRagen brings in Viridian Therapeutics
The acquisition includes clinical stage anti-IGF-1R monoclonal antibody VRDN-001, which is intended for treatment of thyroid eye disease
